Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
- 31 December 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10), 1647-1650
- https://doi.org/10.1016/0959-8049(92)90060-f
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Treatment of Malignant Midgut Carcinoid Tumours with A Long-Acting Somatostatin Analogue OctreotideActa Oncologica, 1991
- RESISTANCE OF METASTATIC PANCREATIC ENDOCRINE TUMOURS AFTER LONG‐TERM TREATMENT WITH THE SOMATOSTATIN ANALOGUE OCTREOTIDE (SMS 201–995)Clinical Endocrinology, 1989
- Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FUActa Oncologica, 1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid SyndromeNew England Journal of Medicine, 1983
- Carcinoid TumorsArchives of Surgery, 1982
- Simple and rapid determination of 5-hydroxyindole-3-acetic acid in urine by direct injection on a liquid chromatographic columnClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Carcinoid TumorsAn analysis of 2837 casesCancer, 1975
- Life history of the carcinoid tumor of the small intestineCancer, 1961